The prognostic value of FMISO-PET-based synchronous tumor and lymph node hypoxia outperforms that of tumor hypoxia only in patients with advanced stage HNSSC-secondary analysis of Dresden FMISO trail
%0 Conference Paper
%1 bandurska2018prognostic
%A Bandurska-Luque, A
%A Loeck, S
%A Haase, R
%A Richter, C
%A Zoephel, K
%A Perrin, R
%A Seidlitz, A
%A Zschaeck, S
%A Appold, S
%A Krause, M
%A others,
%B ONCOLOGY RESEARCH AND TREATMENT
%D 2018
%K imported topic_lifescience
%P 186--186
%T The prognostic value of FMISO-PET-based synchronous tumor and lymph node hypoxia outperforms that of tumor hypoxia only in patients with advanced stage HNSSC-secondary analysis of Dresden FMISO trail
%V 41
@inproceedings{bandurska2018prognostic,
added-at = {2024-11-26T07:55:11.000+0100},
author = {Bandurska-Luque, A and Loeck, S and Haase, R and Richter, C and Zoephel, K and Perrin, R and Seidlitz, A and Zschaeck, S and Appold, S and Krause, M and others},
biburl = {https://puma.scadsai.uni-leipzig.de/bibtex/2888b46be71246c60307f768d64bfbc13/roha044c},
booktitle = {ONCOLOGY RESEARCH AND TREATMENT},
interhash = {5c63c666b97c32d4147f3aab7d5d3be2},
intrahash = {888b46be71246c60307f768d64bfbc13},
keywords = {imported topic_lifescience},
organization = {KARGER ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND},
pages = {186--186},
timestamp = {2024-11-26T07:55:11.000+0100},
title = {The prognostic value of FMISO-PET-based synchronous tumor and lymph node hypoxia outperforms that of tumor hypoxia only in patients with advanced stage HNSSC-secondary analysis of Dresden FMISO trail},
volume = 41,
year = 2018
}
